Article Text

other Versions

PDF
Correspondence
Cardiac MRI as end point in clinical trials
  1. Ingo Eitel,
  2. Steffen Desch,
  3. Holger Thiele
  1. Department of Internal Medicine/Cardiology, University of Leipzig—Heart Center, Leipzig, Germany
  1. Correspondence to Dr Ingo Eitel, Department of Internal Medicine/Cardiology, University of Leipzig—Heart Center, Strümpellstr. 39, 04289 Leipzig, Germany; ingoeitel{at}gmx.de

Statistics from Altmetric.com

To the Editor We read with great interest the recent review article by Alex Pitcher and coworkers highlighting the role of cardiac MRI as a surrogate end point in clinical trials.1 The authors focus on vascular imaging, measurement of infarct size by late gadolinium enhancement (LGE) and measurement of ventricular volumes, …

View Full Text

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Linked Articles

  • PostScript
    Alex Pitcher Deborah Ashby Paul Elliott Steffen E Petersen